A rare-disease gene therapy developed in Philadelphia has cleared a major regulatory hurdle, positioning it on an accelerated path toward approval in the United States and the ...
Questions remain among top Food and Drug Administration officials over who has the appropriate legal authority to sign off on ...
The U.S. Food and Drug Administration has delayed reviews of two drugs chosen for the Trump administration's new fast-track ...
The White House is accelerating a new round of student debt cancellation, aiming to wipe out balances for millions of ...
According to a community announcement, the expansion is aimed at filling critical health care vacancies across Northern Michigan. More than $60,000 in scholarship support will be available in 2026, ...
South Korea’s plan to fast-track AI doctorates reflects a broader effort to strengthen its research competitiveness. Yet the initiative exposes a deeper structural problem — accelerating degrees ...
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Cartography Biosciences, Inc., a biotechnology company advancing a differentiated pipeline of antibody-based cancer therapies, today announced that the ...
Fast Track designation designed to facilitate the development, and expedite the review, of drugs to treat serious conditions and fill an unmet need With Fast Track designation, QTORIN™ rapamycin for ...
Fast Track designation designed to facilitate the development, and expedite the review, of drugs to treat serious conditions and fill an unmet need With Fast Track designation, QTORIN™ rapamycin for ...
US President Donald Trump holding a "Trump Gold Card," introducing his new Gold Card initiative in the Oval Office in the White House on December 10th, 2025. (photo credit: Screenshot via Truth Social ...
On Wednesday, Trump unveiled the "Trump Gold Card" and "Trump Platinum Card," two contribution-based pathways marketed as offering unprecedented access to the United States. The Trump Gold Card offers ...
Dec 9 (Reuters) - The U.S. Food and Drug Administration approved on Tuesday the first drug under its new fast-track program designed to shorten review time for a drug application. The approval for the ...